Literature DB >> 22999128

Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--1.

J Jaime Caro1, Andrew H Briggs, Uwe Siebert, Karen M Kuntz.   

Abstract

Models--mathematical frameworks that facilitate estimation of the consequences of health care decisions--have become essential tools for health technology assessment. Evolution of the methods since the first ISPOR Modeling Task Force reported in 2003 has led to a new Task Force, jointly convened with the Society for Medical Decision Making, and this series of seven articles presents the updated recommendations for best practices in conceptualizing models; implementing state-transition approaches, discrete event simulations, or dynamic transmission models; and dealing with uncertainty and validating and reporting models transparently. This overview article introduces the work of the Task Force, provides all the recommendations, and discusses some quandaries that require further elucidation. The audience for these articles includes those who build models, stakeholders who utilize their results, and, indeed, anyone concerned with the use of models to support decision making.
Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Mesh:

Year:  2012        PMID: 22999128     DOI: 10.1016/j.jval.2012.06.012

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  195 in total

Review 1.  Cost-Effectiveness Models in Age-Related Macular Degeneration: Issues and Challenges.

Authors:  Jordana K Schmier; Carolyn K Hulme-Lowe
Journal:  Pharmacoeconomics       Date:  2016-03       Impact factor: 4.981

Review 2.  Targeting Health Behaviors to Reduce Health Care Costs in Pediatric Psychology: Descriptive Review and Recommendations.

Authors:  Meghan E McGrady; Kevin A Hommel
Journal:  J Pediatr Psychol       Date:  2015-09-10

Review 3.  Including adverse drug events in economic evaluations of anti-tumour necrosis factor-α drugs for adult rheumatoid arthritis: a systematic review of economic decision analytic models.

Authors:  Eleanor M Heather; Katherine Payne; Mark Harrison; Deborah P M Symmons
Journal:  Pharmacoeconomics       Date:  2014-02       Impact factor: 4.981

4.  Circulating Tumour DNA as a Potential Cost-Effective Biomarker to Reduce Adjuvant Chemotherapy Overtreatment in Stage II Colorectal Cancer.

Authors:  Yat Hang To; Koen Degeling; Suzanne Kosmider; Rachel Wong; Margaret Lee; Catherine Dunn; Grace Gard; Azim Jalali; Vanessa Wong; Maarten IJzerman; Peter Gibbs; Jeanne Tie
Journal:  Pharmacoeconomics       Date:  2021-06-05       Impact factor: 4.981

5.  Toward an integrated meta-model of public health dynamics for preparedness decision support.

Authors:  Donald S Burke; John J Grefenstette
Journal:  J Public Health Manag Pract       Date:  2013 Sep-Oct

6.  Value of a Hypothetical Pharmacogenomic Test for the Diagnosis of Statin-Induced Myopathy in Patients at High Cardiovascular Risk.

Authors:  Dominic Mitchell; Jason R Guertin; Jacques LeLorier
Journal:  Mol Diagn Ther       Date:  2018-12       Impact factor: 4.074

7.  Cost-Effectiveness of Fixed-Dose Combinations Therapies for Chronic Obstructive Pulmonary Disease Treatment.

Authors:  Margarita Capel; María Mareque; Carlos José Álvarez; Leandro Lindner; Itziar Oyagüez
Journal:  Clin Drug Investig       Date:  2018-07       Impact factor: 2.859

8.  Decision-analytic models: current methodological challenges.

Authors:  J Jaime Caro; Jörgen Möller
Journal:  Pharmacoeconomics       Date:  2014-10       Impact factor: 4.981

Review 9.  The REVAMP trial to evaluate HIV resistance testing in sub-Saharan Africa: a case study in clinical trial design in resource limited settings to optimize effectiveness and cost effectiveness estimates.

Authors:  Mark J Siedner; Mwebesa B Bwana; Mahomed-Yunus S Moosa; Michelle Paul; Selvan Pillay; Suzanne McCluskey; Isaac Aturinda; Kevin Ard; Winnie Muyindike; Pravikrishnen Moodley; Jaysingh Brijkumar; Tamlyn Rautenberg; Gavin George; Brent Johnson; Rajesh T Gandhi; Henry Sunpath; Vincent C Marconi
Journal:  HIV Clin Trials       Date:  2017-07-18

10.  Multiobjective Calibration of Disease Simulation Models Using Gaussian Processes.

Authors:  Aditya Sai; Carolina Vivas-Valencia; Thomas F Imperiale; Nan Kong
Journal:  Med Decis Making       Date:  2019-08-02       Impact factor: 2.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.